NZ
Business & Markets
Latest New Zealand business & markets news and updates
OpinionBusiness & Markets (NZX)
Hostage to the World: Why the NZX Has Become a Proxy for Global Turbulence
The S&P/NZX 50's recent extreme volatility, driven by Middle East tensions and global AI pricing wars, proves that New Zealand's equity market is increasingly a proxy for global forces. Local investors must wake up to the reality that domestic fundamentals are being overshadowed by international events.
Business & Markets (NZX)
NZX Market Mixed: Tourism Holdings Soars on Takeover Offer as Taiko Reports Loss
New Zealand's sharemarket closed mixed as a massive 24% surge in Tourism Holdings, sparked by a revised NZ$3.10 takeover offer from BGH Capital, offset a widened annual loss of $8.7 million from newly listed Taiko Critical Minerals.
Business & Markets (NZX)
NZX50 Starts Week Modestly Higher Amid Major Corporate Transactions and Headwinds
The New Zealand Exchange's benchmark NZX50 index gained 0.4% on Monday, driven by positive performances from Auckland Airport, Air New Zealand, and Contact Energy. The lift comes amid broader economic challenges, including elevated inflation and high fuel costs.
Business & Markets (NZX)
NZX50 Rises as Oceania Healthcare Surges and Fletcher Building Confirms Unconditional Construction Divestment
The NZX50 index closed up 0.3% on Friday, May 22, 2026, driven by a 9% surge in Oceania Healthcare shares. Concurrently, Fletcher Building announced its Construction Division sale to VINCI Construction is unconditional at an increased value of approximately $334 million.
Business & Markets (NZX)
Tower Limited profit halves to $22.9m as severe weather claims escalate
Tower Limited has reported a significant drop in its half-year profit to $22.9 million, down from $49.7 million a year earlier. The decline was driven by a sharp rise in weather-related claims costing $18.5 million, leading to a slide in the insurer's share price.
Business & Markets (NZX)
Oceania Healthcare Delivers Record Full Year 2026 Results, Reduces Net Debt
Oceania Healthcare has announced its audited full-year results for the period ending March 31, 2026, delivering a record 20% growth in Proforma Underlying EBITDA and a significant reduction in net debt. Despite operational gains, the board has suspended dividends as it targets positive free cash flow.
Business & Markets (NZX)
Napier Port to Commence On-Market Share Buyback Programme Following Revenue Growth
Napier Port Holdings Limited has approved an on-market share buyback of approximately 312,000 shares to support employee ownership plans. The move follows strong half-year results, with revenue rising to $84.9 million.
Business & Markets (NZX)
Air New Zealand Announces Major International Route Expansion from Christchurch
Air New Zealand is set to launch three new non-stop international routes from Christchurch to Singapore, Tokyo, and Perth starting in late 2026, supported by the return of its Boeing 787 fleet.
Business & Markets (NZX)
NZX50 Index Rebounds on Strength from Key Tech and Healthcare Stocks
The NZX50 index climbed 1.2% on Tuesday, recovering from recent losses. Significant gains in Gentrack and Fisher & Paykel Healthcare helped offset broader market declines seen earlier in the week.
Business & Markets (NZX)
Gentrack Group Finalises NZ$24 Million Acquisition of Energy SaaS Provider Factor
Gentrack Group Limited has acquired New Zealand SaaS provider Factor for NZ$24 million to integrate machine learning-driven energy pricing into its global platform. The deal, funded by cash reserves, is expected to be EPS accretive by FY28.
Business & Markets (NZX)
Josh Emett Joins Air New Zealand as Culinary Ambassador to Enhance Onboard Dining Experience
Air New Zealand has appointed Josh Emett as its new Culinary Ambassador to redesign premium dining experiences. The new menus will debut in October 2026 across long-haul flights from Auckland and North America.
Business & Markets (NZX)
NZX50 Index Concludes Week with 1.8% Decline Amid Selective Buying
The NZX50 index fell 0.6% on Friday to close out a difficult week, with the headline index down 1.8% over five days. While Fisher & Paykel Healthcare saw significant losses, Gentrack and Property for Industry recorded gains in a session marked by selective buying.
Business & Markets (NZX)
Mercury Commits up to $1 Billion for Geothermal Energy Expansion
Mercury NZ Limited has announced a phased $1 billion investment plan to expand its geothermal energy platform near Taupō, aiming to power 125,000 additional homes by 2030.
Business & Markets (NZX)
Air New Zealand Revises FY26 Outlook Downward Following Surge in Jet Fuel Costs
Air New Zealand has significantly downgraded its FY26 outlook, forecasting a pre-tax loss of $340 million to $390 million due to a $240 million surge in jet fuel costs. The airline is responding with fare increases and capacity cuts while maintaining a strong liquidity position.
Business & Markets (NZX)
Pacific Edge Secures NZ$25.4 Million in Upsized Capital Placement
Pacific Edge Limited has successfully raised NZ$25.4 million through an upsized placement to fund its Cxbladder operations and efforts to regain US Medicare coverage. The company will now launch a NZ$6 million retail offer to existing shareholders.
Business & Markets (NZX)
J.P. Morgan Re-establishes Substantial Holding in The a2 Milk Company
J.P. Morgan Chase & Co. has disclosed a 5.14% stake in The a2 Milk Company, re-establishing its status as a substantial holder with 37.27 million shares. The move follows a period of stock price volatility and a recent infant formula recall in the United States.
Business & Markets (NZX)
Pacific Edge Halts Trading to Launch NZ$24 Million Capital Raise for Medicare Recovery
Pacific Edge Limited has initiated a trading halt to conduct a NZ$24 million capital raise aimed at regaining US Medicare coverage. The company reported a significant revenue drop to NZ$11.5 million in FY26 following the loss of reimbursement for its Cxbladder tests.
Business & Markets (NZX)
NZX 50 Ends Week Lower Amid Geopolitical Tensions
The NZX 50 index closed at 13,175 points on Friday, May 8, 2026, marking a daily decline of 0.72%. Despite the fall, the market secured a 1.7% weekly gain and remains up 4.52% over the past year.
Business & Markets (NZX)
NZX 50 Sees Strong Gains Led by Gentrack and Infratil on Thursday
The NZX 50 index climbed 0.9% to 13271 points on Thursday, led by an 11% surge in Gentrack and a 3% gain for Infratil. While technology and infrastructure stocks thrived on AI optimism, consumer-facing companies like SkyCity and Tourism Holdings saw declines.
Business & Markets (NZX)
CDC Data Centres secures record 555-megawatt contract in Australia
CDC Data Centres has secured a landmark 555-megawatt contract in Australia, the largest in the nation's history. The 30-year agreement with a high-end US customer is expected to drive annualised EBITDAF to A$2 billion.